AMANDA MATA: Open Payments
NPI 1174050272 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 30 payments from 16 companies in 2025. Trend: 2023 $72 · 2024 $138 · 2025 $826
Food & beverage: $566Education: $260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $174 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| SEAGEN INC. | 1 | $80 |
| Janssen Biotech, Inc. | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Daiichi Sankyo Inc. | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Astellas Pharma US Inc | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Celgene Corporation | 1 | $32 |
Products named: VENCLEXTA, SARCLISA, Enhertu, TALVEY, LIBTAYO, OJJAARA, Nubeqa, REBLOZYL.
Industry payments across TX — which companies pay providers there.
